ASK ABOUT OUR PRICE MATCH POLICY
QUESTION? CONTACT US
26,000+ 5-STAR RATINGS ON SHOPPER APPROVED
The world´s most precise portable PT/INR monitoring system ever. Unmatched clinical performance using direct mechanical clot detection. This simplistic approach to PT/INR testing has delivered a stellar clinical performance history since its introduction. Now you can get direct clot detection PT/INR technology in a sleek little package with all the bells and whistles including Wi-Fi, Bluetooth®, Near Field Connectivity (NFC) and a color touch screen to control it all.
The most precise POC PT/INR system ever.
When clinicians and researchers want the most accurate means of determining prothrombin time, they turn to either the World Health Organization (WHO) mechanical tilt tube technique or the Fibrometer. Both these methods use a mechanical approach to directly detect clot formation, but they are cumbersome to perform. The Coag-Sense® PT/INR Monitoring System represents a breakthrough in point-of-care prothrombin time monitoring technology by miniaturizing and simplifying a direct mechanical means of detecting clot formation. Coag-Sense® is the only true prothrombin timer on the market. Everything else is guessing at when it thinks a clot has formed.
Super-accurate direct mechanical detection.
By directly detecting the clot, the Coag-Sense® system avoids the challenges that plague other systems that use secondary means of clot detection like monitoring changes in impedance. For example, the concentration of red blood cells or other substances in blood sample can affect results in the measurement process of those products. The Coag-Sense system simply lifts the fibrin clot from the reaction well which interrupts a simple light beam. The PT time is the actual time from when the blood sample is applied to when the clot is formed. This produces results similar to the gold standard WHO tilt-tube method.
|California Prop 65||
⚠️ WARNING: This product can expose you to chemicals including arsenic, which is known to the State of California to cause cancer. For more information, visit Proposition 65